Platelets release mitochondrial antigens in systemic lupus erythematosus
The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Platelets are a source of extracellular DNA and mitochondrial antigens in systemic lupus erythematosus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The plasma of patients with SLE contains elevated levels of extracellular vesicle-containing immune complexes compared with healthy individuals, the presence of which is associated with anti-dsDNA antibodies, pro-inflammatory cytokines and disease activity213–217.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [214]
In the citing paper
“In a similar fashion, numerous stimuli, including immune complexes and their combination with TLR ligands, are able to induce platelet activation and subsequent release of extracellular mitochondria214,215.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [214]
In the citing paper
“Data from transgenic animals and mice with fluorescently labelled mitochondria suggest that, in models of SLE, platelets are a notable source of mtDNA, most of which is contained in naked mitochondria214.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [214]
In the citing paper
“Intriguingly, most of the mtDNA present in the plasma of patients with SLE originates from naked mitochondria214.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [214]
In the citing paper
“Because of their number, platelets are the main reservoir of mitochondria in the blood, and thus the principal source of extracellular mitochondria214.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [214]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
Sun, L., Wu, J., Du, F., Chen, X., & Chen, Z. J. (2013) · Science · doi:10.1126/science.1232458 · Cited by 4,996 · cited 3×
“Once internalized by cells, these mitochondria may activate intracellular DNA sensors (12, 13).”
BackgroundNovel cell death program leads to neutrophil extracellular traps
Fuchs, T. A., Abed, U., Goosmann, C., Hurwitz, R., Schulze, I., Wahn, V., Weinrauch, Y., Brinkmann, V., & Zychlinsky, A. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200606027 · Cited by 3,197
Gladman, D., Ginzler, E., Goldsmith, C., Fortin, P., Liang, M., Sanchez‐Guerrero, J., Urowitz, M., Bacon, P., Bombardieri, S., Hanly, J., et al. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390303 · Cited by 2,582
Self-citationChromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchik, M. J., & Marshak-Rothstein, A. (2002) · Nature · doi:10.1038/416603a · Cited by 1,900
Lood, C., Blanco, L. P., Purmalek, M. M., Carmona-Rivera, C., De Ravin, S. S., Smith, C. K., Malech, H. L., Ledbetter, J. A., Elkon, K. B., & Kaplan, M. J. (2016) · Nature Medicine · doi:10.1038/nm.4027 · Cited by 1,570
Self-citationMitochondria in innate immune responses
West, A. P., Shadel, G. S., & Ghosh, S. (2011) · Nature Reviews Immunology · doi:10.1038/nri2975 · Cited by 1,376
New insights into the immunopathogenesis of systemic lupus erythematosus
Tsokos, G. C., Lo, M. S., Reis, P. C., & Sullivan, K. E. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.186 · Cited by 1,226 · cited 1×
“Although the mechanisms underlying the initiation and progression of the disease are still not well understood, it is currently accepted that the accumulation of autoantibodies and autoantigens (DNA and nucleus components) (2) in blood, the formation of antibody-antigen scaffolds called immune complexes (ICs), and the…”
BackgroundNew mitochondrial DNA synthesis enables NLRP3 inflammasome activation
Zhong, Z., Liang, S., Sanchez-Lopez, E., He, F., Shalapour, S., Lin, X.-J., Wong, J., Ding, S., Seki, E., Schnabl, B., et al. (2018) · Nature · doi:10.1038/s41586-018-0372-z · Cited by 1,208
Research works printed but not linked: 1
- 10.1172/JCI23025 · doi:10.1172/jci23025 · Paper page
Cited by
Mitochondrial control of inflammation
Marchi, S., Guilbaud, E., Tait, S. W. G., Yamazaki, T., & Galluzzi, L. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00760-x · Cited by 1,027
The role of platelets in immune-mediated inflammatory diseases
Scherlinger, M., Richez, C., Tsokos, G. C., Boilard, E., & Blanco, P. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00834-4 · Cited by 346
Recommendations for mitochondria transfer and transplantation nomenclature and characterization
Brestoff, J. R., Singh, K. K., Aquilano, K., Becker, L. B., Berridge, M. V., Boilard, E., Caicedo, A., Crewe, C., Enríquez, J. A., Gao, J., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-024-01200-x · Cited by 170
“By contrast, mtDNA contained in ex-Mito should be susceptible to DNase I digestion after the addition of detergent 122 .”
InfluentialAutoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target
Lou, H., Ling, G. S., & Cao, X. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102861 · Cited by 158
Mitochondria-derived cell-to-cell communication
Dache, Z. A. A., & Thierry, A. R. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112728 · Cited by 172
D’Acunzo, P., Kim, Y., Ungania, J. M., Pérez‐González, R., Goulbourne, C. N., & Levy, E. (2022) · Nature Protocols · doi:10.1038/s41596-022-00719-1 · Cited by 172
The immunology of systemic lupus erythematosus
Tsokos, G. C. (2024) · Nature Immunology · doi:10.1038/s41590-024-01898-7 · Cited by 160
“Specifically, mitochondrial DNA released from red blood cells 140 , platelets 141 and neutrophils 142 is increased in the circulation of individuals with SLE and contributes to disease pathogenesis.”
Immunopathogenesis of systemic lupus erythematosus: An update
Arnaud, L., Chasset, F., & Martin, T. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103648 · Cited by 144
Platelets: Orchestrators of immunity in host defense and beyond
Nicolai, L., Pekayvaz, K., & Maßberg, S. (2024) · Immunity · doi:10.1016/j.immuni.2024.04.008 · Cited by 135
Platelets and diseases: signal transduction and advances in targeted therapy
Tian, Y., Yao, Z., Pang, Y., Zheng, Z., Ma, Y., Zhang, C., & Gao, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02198-8 · Cited by 143
“442 Additionally, mtDNA, a prototypical DAMP molecule and a strong inducer of type I interferon (IFN) production, is taken up by cells and detected by pattern recognition receptors, 443 activating cGAS pathway and IFN production, leading to pro-in fl ammatory response.”
Oxidized mitochondrial DNA induces gasdermin D oligomerization in systemic lupus erythematosus
Miao, N., Wang, Z., Wang, Q., Xie, H., Yang, N., Wang, Y., Wang, J., Kang, H., Bai, W., Wang, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36522-z · Cited by 125
Marcoux, G., Laroche, A., Hasse, S., Bellio, M., Mbarik, M., Tamagne, M., Allaeys, I., Zufferey, A., Lévesque, T., Rebetz, J., et al. (2021) · Blood · doi:10.1182/blood.2020009957 · Cited by 108
Self-citationPathogenic cellular and molecular mediators in lupus nephritis
Mohan, C., Zhang, T., & Putterman, C. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00722-z · Cited by 105
The role of mitochondria in rheumatic diseases
Becker, Y. L. C., Duvvuri, B., Fortin, P. R., Lood, C., & Boilard, E. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00834-z · Cited by 81
Self-citationAn update on autoantibodies in systemic lupus erythematosus
Gómez-Bañuelos, E., Fava, A., & Andrade, F. (2022) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000922 · Cited by 90
Systemic lupus erythematosus-complicating immune thrombocytopenia: From pathogenesis to treatment
Jiang, Y., Cheng, Y., Ma, S., Li, T., Chen, Z., Zuo, X., & Zhang, X. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102887 · Cited by 76
Pregnancy-related complications in systemic lupus erythematosus
Tan, Y., Yang, S., Liu, Q., Li, Z., Mu, R., Qiao, J., & Cui, L. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102864 · Cited by 73
Immunometabolism in systemic lupus erythematosus
Patiño‐Martínez, E., & Kaplan, M. J. (2025) · Nature Reviews Rheumatology · doi:10.1038/s41584-025-01267-0 · Cited by 77
“SLE platelets release mDNA following FcγRIIA stimulation by immune complexes, with prointerfero-genic consequences 40 .”
Dermatologic Manifestations of Mitochondrial Dysfunction: A Review of the Literature
Natarelli, N., Gahoonia, N., Aflatooni, S., Bhatia, S., & Sivamani, R. K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063303 · Cited by 59
“This finding suggests that mitochondrial release by platelets is a major source of autoantigens in patients with SLE [54].”
BackgroundMitochondrial impairment and repair in the pathogenesis of systemic lupus erythematosus
Zhao, L., Hu, X., Xiao, F., Zhang, X., Zhao, L., & Wang, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.929520 · Cited by 64
Secretion of mitochondrial DNA via exosomes promotes inflammation in Behçet's syndrome
Konaka, H., Kato, Y., Hirano, T., Tsujimoto, K., Park, J., Koba, T., Aoki, W., Matsuzaki, Y., Taki, M., Koyama, S., et al. (2023) · The EMBO Journal · doi:10.15252/embj.2022112573 · Cited by 55
“Additionally, leaked mtDNA has been reported to be involved in several human diseases, including trauma-related acute respiratory disease syndrome, heart failure, and systemic lupus erythematosus (SLE) (Zhang et al , 2010; Oka et al , 2012; Lood et al , 2016; Melki et al , 2021).”
BackgroundPelletier, M., Breton, Y., Allaeys, I., Becker, Y. L. C., Benson, T., & Boilard, É. (2023) · Transfusion · doi:10.1111/trf.17524 · Cited by 51
Self-citationZhang, J., Ji, H., Liu, M., Zheng, M., Wen, Z., & Shen, H. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2300758 · Cited by 54
Mitochondria in the Pathogenesis of Systemic Lupus Erythematosus
Chen, P.-M., & Tsokos, G. C. (2022) · Current Rheumatology Reports · doi:10.1007/s11926-022-01063-9 · Cited by 53
Roles of Mitochondrial DNA Damage in Kidney Diseases: A New Biomarker
Feng, J., Chen, Z., Liang, W., Wei, Z., & Ding, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315166 · Cited by 50
“studies have reported that mtDNA leaking into the cytoplasm can act as an inflammatory mediator and activate the natural immune inflammatory response [6,7].”
BackgroundGomchok, D., Ge, R.-L., & Wuren, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914724 · Cited by 44
“Once activated, platelets begin to change shape and surface molecules, degranulate, and release organelles and microvesicles or molecules in response to different stimuli [14,17,18].”
Platelet extracellular vesicles in COVID-19: Potential markers and makers
Puhm, F., Flamand, L., & Boilard, É. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mir0221-100r · Cited by 42
Giaglis, S., Daoudlarian, D., Voll, R. E., Kyburz, D., Venhoff, N., & Walker, U. A. (2021) · RMD Open · doi:10.1136/rmdopen-2021-002010 · Cited by 38
Wang, H., Shen, M., Ma, Y., Lan, L., Xue, J., Cen, X., Guo, G., Zhou, Q., Yuan, M., Chen, J., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.12.017 · Cited by 38
Plasma mtDNA as a possible contributor to and biomarker of inflammation in rheumatoid arthritis
Lehmann, J., Giaglis, S., Kyburz, D., Daoudlarian, D., & Walker, U. A. (2024) · Arthritis Research & Therapy · doi:10.1186/s13075-024-03329-2 · Cited by 38
“Since platelets release mtDNA in vitro during clot formation and activation [35], thereby artefactually increasing mtDNA measurements [35, 36], our analysis was unlike that of all previous investigators [4, 5, 19] done with platelet-poor plasma and not with serum thus adhering to current guidelines…”
ResultMitochondrial Dysfunction in Systemic Lupus Erythematosus with a Focus on Lupus Nephritis
Halfon, M., Tankeu, A. T., & Ribi, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116162 · Cited by 40
Ma, R., Maharajan, K., Zhuang, K., Xia, Q., Sun, D. B., Tu, P., Fan, T.-P., Liu, K., & Zhang, Y. L. (2023) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2022.08.011 · Cited by 35
Extracellular DNA Traps: Origin, Function and Implications for Anti-Cancer Therapies
Mamtimin, M., Pinarci, A., Han, C., Braun, A., Anders, H., Gudermann, T. W., & Mammadova‐Bach, E. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.869706 · Cited by 39
Platelet extracellular vesicles and the secretory interactome join forces in health and disease
Boilard, É., & Bellio, M. (2022) · Immunological Reviews · doi:10.1111/imr.13119 · Cited by 35
Platelet LGALS3BP as a Mediator of Myeloid Inflammation in Systemic Lupus Erythematosus
Bannoudi, H. E., Cornwell, M., Luttrell-Williams, E. S., Engel, A., Rolling, C. C., Barrett, T. J., Izmirly, P., Belmont, M. H., Ruggles, K. V., Clancy, R. M., et al. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42382 · Cited by 35
“Inflammatory stimuli characteristic of SLE, including immune complexes, activate platelets (6,7,30).”
BackgroundMitochondria as a key player in systemic lupus erythematosus
Quintero-González, D. C., Muñoz-Urbano, M., & Vásquez, G. M. (2022) · Autoimmunity · doi:10.1080/08916934.2022.2112181 · Cited by 39
“complex-induced mtDNA extrusion from platelets [69].”
Mitochondria in aging and age-associated diseases
Pahal, S., Mainali, N., Balasubramaniam, M., Reis, R. J. S., & Ayyadevara, S. (2025) · Mitochondrion · doi:10.1016/j.mito.2025.102022 · Cited by 33
Antigen transfer and its effect on vaccine-induced immune amplification and tolerance
Shi, Y., Lu, Y., & You, J. (2022) · Theranostics · doi:10.7150/thno.75904 · Cited by 28
“Moreover, individuals with autoimmune diseases, such as systemic lupus erythematosus (SLE) that produces systemic inflammation in multiple organs, have platelets that continuously recruit and release mitochondrial DNA (mtDNA) as a source of circulating autoantigen to exacerbate the self-attack of immune system [146].”
BackgroundBecker, Y. L. C., Gagné, J., Julien, A., Lévesque, T., Allaeys, I., Gougeard, N., Rubio, V., Boisvert, F., Jean, D., Wagner, E., et al. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42082 · Cited by 26
Self-citationPlatelet mitochondria: the mighty few
Ajanel, A., Campbell, R. A., & Denorme, F. (2023) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000772 · Cited by 31
González-Chapa, J. A., Macêdo, M. B., & Lood, C. (2023) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10493 · Cited by 29
Self-citationZhang, F., Zhang, B., Ding, H., Li, X., Wang, X., Zhang, X., Liu, Q., Feng, Q., Han, M., Chen, L., et al. (2023) · Advanced Science · doi:10.1002/advs.202207108 · Cited by 32
Husna, N., Aiba, T., Fujita, S.-I., Saito, Y., Shiba, D., Kudo, T., Takahashi, S., Furukawa, S., & Muratani, M. (2024) · Nature Communications · doi:10.1038/s41467-023-41995-z · Cited by 30
“These results indicated that mitochondrial components were released into theplasmaduringspace fl ightascomponentsofCD36-markedEVs,but that this fraction was distinct from EVs derived from platelet degranulation 43,44 .”
tRF-His-GTG-1 enhances NETs formation and interferon-α production in lupus by extracellular vesicle
Chen, Y., Tang, K., Liu, H., Huang, S., & Liao, T. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01730-7 · Cited by 26
“Melki et al. [3] demonstrated that in lupus-prone transgenic mice, ICs triggered platelet activation and released mitochondrial antigens.”
BackgroundZhao, Y., Wu, C., Liang, X., & Yang, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1640748 · Cited by 30
“In SLE patients, the release of mtDNA is linked to platelet degranulation mediated by platelet Fc g RIIA and the fi brinogen receptor a 2b b 3 (101).”
Suwakulsiri, W., Xu, R., Rai, A., Shafiq, A., Chen, M., Greening, D. W., & Simpson, R. J. (2023) · PROTEOMICS · doi:10.1002/pmic.202300057 · Cited by 24
“However, it is evident that mitochondrial bodies can be released from cells as mitovesicles and transferred to recipient cells [53, 54].”
BackgroundOstermeier, B., Soriano-Sarabia, N., & Maggirwar, S. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042321 · Cited by 20
Extracellular vesicles: effectors of transfusion-related acute lung injury
Kuebler, W. M., William, N., Post, M., Acker, J. P., & McVey, M. J. (2023) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00040.2023 · Cited by 22
Roch, B., Pisareva, E., Mirandola, A., Sánchez, C., Pastor, B., Tanos, R., Frayssinoux, F., Diab‐Assaf, M., Anker, P., Dache, Z. A. A., et al. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117711 · Cited by 23
Thierry, A. R., & Salmon, D. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29887 · Cited by 22
“67 They suggest that the presence of circulating DNA leads to the formation of antigen − antibody complexes, which accumulate in those tissues where the disease is expressed.”
Seewald, L. A., Sabino, I., Montney, K. L., & Delco, M. L. (2023) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2023.03.013 · Cited by 20
Yin-Yang: two sides of extracellular vesicles in inflammatory diseases
Zeng, B., Li, Y., Khan, N., Su, A., Yang, Y., Mi, P., Jiang, B., Liang, Y., & Duan, L. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02779-9 · Cited by 17
“…POR [180] Mycomembrane vesicles Bacteria Mycomembrane NA DtHtaA [272, 281] Mitovesicles Mammal Mitochondrion 100–200 nm COX-IV,PDH-E1α, HSP60 [45, 173] Necroptotic EVs Mammal Plasma membrane 150–200 nm MLKL, RIPK3 [226, 305] Pyroptotic bodies Mammal Plasma membrane 1–5 μm Cleaved caspase1,…”
BackgroundPlatelet Extracellular Vesicles as Natural Delivery Vehicles for Mitochondrial Dysfunction Therapy?
Yeh, H. C., Gupta, K., Lu, Y.-H., Srinivasan, A., Delila, L., Yen, N. T. H., Nyam‐Erdene, A., & Burnouf, T. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c00473 · Cited by 17
“189,190 Increased levels of sPLA2-IIA have been detected in the synovial fluid of rheumatoid arthritis (RA) patients, contributing to disease progression.”
Hasse, S., Julien, A., Duchez, A., Zhao, C., Boilard, É., Fortin, P. R., & Bourgoin, S. G. (2022) · Lupus Science & Medicine · doi:10.1136/lupus-2021-000605 · Cited by 16
Self-citationHuang, X., Liu, Y., Ling, G., & Cao, X. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110519 · Cited by 15
Platelets in Alcohol-Associated Liver Disease: Interaction With Neutrophils
Wang, J., Wang, X., Peng, H., Dong, Z., Liangpunsakul, S., Zuo, L., & Wang, H. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.03.001 · Cited by 15
“24,25 Asialo-glycoprotein receptor is on the surface of liver parenchymal cells, it serves as the primary receptor responsible for recognizing, adhering to, and clearing damaged platelets through phagocytosis.”
BackgroundLi, H., Zhou, L., Zhou, W., Zhang, X., Shang, J., Feng, X., Yu, L., Fan, J., Ren, J., Zhang, R., et al. (2024) · Rheumatology & autoimmunity · doi:10.1002/rai2.12119 · Cited by 15
Prediction of Erosive Disease Development by Antimitochondrial Antibodies in Rheumatoid Arthritis
Moore, R. E., Wang, T., Duvvuri, B., Feser, M. L., Deane, K. D., Solomon, J. J., Nelson, J. L., Demoruelle, M. K., & Lood, C. (2023) · Arthritis & Rheumatology · doi:10.1002/art.42428 · Cited by 15
“Other than cell death, intact mitochondria can also be released upon platelet activation (2), with recent findings from research in lupus-prone mice highlighting platelets as the main source of extracellular mitochondria (23).”
BackgroundSelf-citationWang, X., Cui, N., Fang, Z.-Q., Gao, M.-J., & Cai, D. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103146 · Cited by 14
“Exposure to increased mtROS may pathologically induce the production of oxidized mitochondrial DNA [56], which can be released by platelets as a strong inducer of granule secretion in the disease states like ISR [57].”
BackgroundPlatelets are a major player and represent a therapeutic opportunity in systemic lupus erythematosus
Robert, M., & Scherlinger, M. (2023) · Joint Bone Spine · doi:10.1016/j.jbspin.2023.105622 · Cited by 14
Platelets as drivers of immunothrombosis in rheumatic diseases
Maugeri, N., & Manfredi, A. A. (2025) · Nature Reviews Rheumatology · doi:10.1038/s41584-025-01276-z · Cited by 15
The mechanisms and functions of mitochondria-encapsulating extracellular vesicles
Sheng, D., Chen, X., Shi, J., & Tang, H. (2025) · Science China Life Sciences · doi:10.1007/s11427-024-2905-5 · Cited by 14
Hasse, S., Duchez, A., Fortin, P. R., Boilard, É., & Bourgoin, S. G. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114667 · Cited by 9
Self-citationDuchez, A., Fauteux‐Daniel, S., Ebermeyer, T., Heestermans, M., Arthaud, C., Eyraud, M., Prier, A., Audoux, E., Portais, J., Bertrand‐Michel, J., et al. (2023) · Blood transfusion · doi:10.2450/2022.0144-22 · Cited by 9
Mitochondrial DNA: a novel indicator of active inflammation in ANCA-associated vasculitides
Giaglis, S., Daoudlarian, D., Thiel, J., Rizzi, M., Kyburz, D., Venhoff, N., & Walker, U. A. (2023) · Rheumatology · doi:10.1093/rheumatology/kead015 · Cited by 10
“Platelets, for example, contain mtDNA, are also activated in AAV [40] and represent another possible source of mtDNA in AAV [41].”
Platelet extracellular vesicles: Darkness and light of autoimmune diseases
Chen, J., Wang, M., Zhang, Y., Zhu, F., Xu, Y., Yi, G., Zheng, R., & Wu, B. (2023) · International Reviews of Immunology · doi:10.1080/08830185.2023.2225551 · Cited by 9
“This process may be mediated by the stimulation of platelet FcγRIIA, a receptor for IC, which promotes PEVs-mtDNA release [33].”
BackgroundErythrocyte-derived mitochondria: an unexpected interferon inducer in lupus
Morel, L. M. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.10.010 · Cited by 9
Lynch, D., Stringham, E. N., Zhang, B., Balbin-Cuesta, G., Curtis, B. R., Palumbo, J. S., Greineder, C. F., & Tourdot, B. E. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022007195 · Cited by 10
“The ability of scIV.3-IdeS to degrade surface-bound IgG is predicated on it being retained on the cell surface; however, previous work demonstrated engagement of FcgRIIA with divalent IV.3 caused receptor internalization.14 We therefore sought to determine whether our monovalent ligand, scIV.3, caused receptor interna…”
BackgroundInfluentialImmune thrombocytopenia in patients with systemic lupus erythematosus
Zheng, Z., Liu, J., Yun, M., Deng, L., Xiang, P., Jiang, M., Wang, R., & Liu, C. (2024) · Clinical Rheumatology · doi:10.1007/s10067-024-07235-5 · Cited by 8
“Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune disorder characterized by a broad auto-immune response that may lead to damage in multiple organs and systems throughout the body, including hematologic abnormalities [1, 2].”
Presence and possible impact of Fcγ receptors on resident kidney cells in health and disease
Typiak, M. J., Audzeyenka, I., & Dubaniewicz, A. (2022) · Immunology and Cell Biology · doi:10.1111/imcb.12570 · Cited by 11
“Interestingly, FccRIIa has been implicated in the recruitment of platelets and release of mitochondrial content (e.g. mitochondrial DNA) in the kidneys, which promotes the development of LN.71 Increased mitochondrial ROS generation has been proposed as an essential initiation factor in the mechanism of mitochondrial D…”
BackgroundInfluentialLian, Q., Liu, H., Li, J., Luo, C., Liu, C., Zhao, H., Dai, P., Wang, B., Zhou, H., Jiang, X. J., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03417-4 · Cited by 7
“ITGB3 (integrin subunit beta 3) forms the integrins α2bβ3 (with ITGA2B) and αvβ3 (with ITGAV), which play important physiological roles as transmembrane glycoproteins [19, 20].”
Zheng, Z., Liu, J., He, T., & Liu, C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1606510 · Cited by 7
Platelet’s plea to Immunologists: Please do not forget me
Kumar, V., & Stewart, J. H. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113599 · Cited by 10
Mitochondria dysfunction: A trigger for cardiovascular diseases in systemic lupus erythematosus
Wang, H., Tang, R., Pan, Q., Yin, Q., Feng, J., & Deng, L. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113722 · Cited by 10
Erythrocyte-derived mitochondria take to the lupus stage
Lepelley, A., & Crow, Y. J. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.08.008 · Cited by 7
Cigarette Tar Enhanced ECs Pyroptosis via CAMKII/Drp1/mtDNA
Luo, X., Li, J., Chen, Y., Weng, X., Bao, X., Bai, X., Lv, Y., Zhang, S., Zhu, X., Xu, B., et al. (2025) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2025.03.015 · Cited by 7
Anti-TFAM antibodies link mitochondrial damage with antiphospholipid syndrome and thrombosis in SLE
Gómez-Bañuelos, E., Celia, A. I., Trejo‐Zambrano, M. I., Anda, J.-A. R.-D., Paz, M., Chaturvedi, S., Conti, F., Alessandri, C., Tiniakou, E., GOLDMAN, D. W., et al. (2025) · Annals of the Rheumatic Diseases · doi:10.1016/j.ard.2025.04.015 · Cited by 7
Ma, J., Zhang, L., Yan, M., Liu, Z., & Xue, L. (2025) · Immunity Inflammation and Disease · doi:10.1002/iid3.70201 · Cited by 4
“Melki et al. reported that platelets released mitochondrial DNA via Fc γ RIIA upon stimulation with immune complexes in patients with SLE and mouse models [18].”
InfluentialLin, D., Yang, H., Liang, X., Yang, M., & Zhao, Y. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01555-1 · Cited by 4
“…of the oxidized form of mtDNA (ox-mtDNA) in the bloodstream, which is highly immunogenic and may promote pathogenic type I interferon responses [63, 64]. mtDNA facilitates type I IFN responses through the activation of the cGAS-STING signaling pathway or by binding to TLR9, thereby initiating…”
Yang, K., Bi, J., Cao, Y., He, D., Fu, S., & Guo, W. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.03.048 · Cited by 5
Becker, Y. L. C., Boilard, É., Rollet-Labelle, E., Lood, C., Julien, A.-S., Abrahamowicz, M., Allaeys, I., Choi, M., Leclerc, J., Lévesque, T., et al. (2026) · Annals of the Rheumatic Diseases · doi:10.1016/j.ard.2025.11.007 · Cited by 3
Self-citationMegakaryocytes as mitochondria factories: potential donors for mitochondria transplantation
Mercure, É., Pelletier, M., & Boilard, É. (2025) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000889 · Cited by 3
Bellio, M., Allaeys, I., Doré, É., Vaillancourt, M., Lévesque, T., Monteil, M., Vallières, N., Desaulniers, P., Bertrand, N., Washington, A. V., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci195987 · Cited by 3
“The blockade of Fc γ RIIA with monoclonal anti-Fc γ RIIA–blocking antibodies completely abrogated the interaction, consistent with prior studies showing that this receptor is required for IC-platelet interactions (45, 46).”
InfluentialSelf-citationNi, R., Barrett, T. J., & Garshick, M. S. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.047468 · Cited by 3
“45 FcyRIIA-mediated platelet activation also leads to GPIIb/IIIa conformational change and enhanced fibrinogen-platelet cross-linking, promoting thrombosis.”
Cytoplasmic DNA sensing boosts CD4+ T cell metabolism for inflammatory induction
Ye, J., Fu, J., Hou, H., Wang, Y., Deng, W., Hao, S., Pei, Y., Xu, J., Zheng, M., & Xiao, Y. (2023) · Life Medicine · doi:10.1093/lifemedi/lnad021 · Cited by 4
The platelet-mitochondria nexus in autoimmune and musculoskeletal diseases
Michailidou, D., Giaglis, S., & Dale, G. L. (2024) · Clinical Immunology · doi:10.1016/j.clim.2024.110350 · Cited by 3
Platelet Fc gamma RIIA: time to go beyond the unknown
Andrianova, I. A., Thubthed, R., & Denorme, F. (2025) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000881 · Cited by 3
An Insight into Platelets at Older Age: Cellular and Clinical Perspectives
Rojas-Sánchez, G., & Davizon‐Castillo, P. (2023) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-21410-3_13 · Cited by 3
Mitochondrial dysfunction in the erythroid compartment
Kaplan, M. J. (2021) · Nature Immunology · doi:10.1038/s41590-021-01050-9 · Cited by 3
Mitochondrial transplantation and its impact on infectious disease progression: a pilot studyPreprint
Benson, T., Patel, S. P., Albensi, B. C., Mahajan, V. B., Adlimoghaddam, A., Sikora, S., & Saitō, H. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.08.556161 · Cited by 3
Mitochondrial Transplantation in the Eye: A Review and Evaluation of Surgical ApproachesPreprint
Cakir, B., Yeh, T.-C., Lin, C., Wu, M.-R., Boilard, É., Pelletier, M., Singh, A., Breton, Y., Patel, S. P., Benson, T., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.06.716722 · Cited by 4
“98,99 Briefly, following cervical dislocation, livers were excised, rinsed, and homogenized in ice-cold mitochondrial isolation buffer.”
Blood transfusion and the presence of biological structures in the circulation
Tanos, R., & Thierry, A. R. (2022) · Cellular and Molecular Biology · doi:10.14715/cmb/2022.68.10.1 · Cited by 2
“We recently found that platelet activation during standard plasma preparation led to the release of ~376x10 6 full-length mtDNA copies per mL of plasma from healthy individuals, which approximately correspond to about 40 to 125 x10 6 mitochondria per mL (40,41).”
BackgroundGeorges, N., Fuentes, C., Hidalgo, Y., Grünenwald, F., Corrales-Bermúdez, J., Figueroa‐Valdés, A. I., Ramírez-Pereira, M., Arriagada, G., Bustos, F. J., Ahumada-Marchant, C., et al. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218457 · Cited by 2
Platelets fuel mesenchymal stem cells by providing live mitochondria
Zhao, Z., Zhang, J., & Dong, J. (2021) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15295 · Cited by 3
Zhang, X., Zhang, L., Shi, C., Yan, L., Geng, Q., Yuan, S., He, X., & Lü, C. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70392 · Cited by 1
Jiang, W., Tang, W. H., & Zhang, Y. (2026) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00610.2025 · Cited by 2
Clotting the Gap Between Mitochondria-Mediated Immunity and Mitochondrial Transfer
Tupin, F., González-Chapa, J. A., Chung, J. H., Lood, C., & Boilard, É. (2026) · Circulation Research · doi:10.1161/circresaha.125.326987 · Cited by 2
Self-citationMegakaryocytes Internalize and Are Activated by Immune Complexes
Puhm, F., Allaeys, I., Petito, E., Sang, Y., Tupin, F., ANDRADE, A. D., Doré, É., Dubuc, I., Vaillancourt, M., Dieudé, M., et al. (2026) · Circulation Research · doi:10.1161/circresaha.125.327999 · Cited by 1
“HA-IgG are 160±7 nm in diameter 12,28,29 and were confirmed free of detectable endotoxin ( 0.1 Endotoxin Units·mL −1 ).”
InfluentialSelf-citationPan, Y., Zhao, W., Yu, B., Zhang, J., Qu, M., Jiang, R., Xu, T., Li, D. M., Zhang, H., & Miao, C. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-03061-1 · Cited by 1
“Subsequently, released mitochondria and mtDNA are highly immunogenic structures that stimulate immune cells to produce type I interferons and can also deposit in the kidney in association with immune complexes, thereby triggering or exacerbating lupus nephritis [104].”
Huang, F., Sun, K., Diao, L., Lu, K., Fan, Y., & Xie, G. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1928003 · Cited by 2
Metadata
- Authors
- Melki, I., Allaeys, I., Tessandier, N., Lévesque, T., Cloutier, N., Laroche, A., Vernoux, N., Becker, Y., Benk-Fortin, H., Zufferey, A., Rollet-Labelle, E., Pouliot, M., Poirier, G., Patey, N., Belleannee, C., Soulet, D., McKenzie, S. E., Brisson, A., Tremblay, M.-E., Lood, C., Fortin, P. R., & Boilard, E.
- Affiliations
- Centre de Recherche du Centre Hospitalier Universitaire de Québec–Université Laval, Québec, QC G1V 4G2, Canada.
- Centre hospitalier universitaire de Québec (CA)
- Université Laval (CA)
- Centre Hospitalier Universitaire Sainte-Justine (CA)
- Department of Obstetrics, Gynecology and Reproduction, Centre hospitalier universitaire de Québec–Université Laval et Département de médecine moléculaire de l’Université Laval, Québec, QC G1V 4G2, Canada.
- Thomas Jefferson University (US)
- Centre National de la Recherche Scientifique (FR)
- Axe Neurosciences du Centre de Recherche du Centre Hospitalier Universitaire de Québec–Université Laval et Département de Médecine Moléculaire de l’Université Laval, Québec, QC G1V 4G2, Canada.
- University of Washington (US)
- Corresponding author
- Fortin, Paul R.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2021-02-17
- Volume
- 13
- Issue
- 581
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W3132953708
- Cited by
- 125
- References
- 65
- Citations by year
- 2026: 17 · 2025: 23 · 2024: 26 · 2023: 27 · 2022: 22 · 2021: 10
- FWCI
- 16.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Oskar-Bordeaux (Universite de Bordeaux) (submittedVersion)
- Funders
- Lupus Research Alliance
- Canadian Institutes of Health Research
- Arthritis Society
- Canada Research Chairs
- The Fonds de recherche du Québec – Santé
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Keywords
- systemic lupus erythematosus, platelets, mitochondrial DNA, extracellular mitochondria, autoantigens, platelet secretion, FcγRIIa, immune complexes, autoantibodies, lupus-prone mice, therapeutic target
- MeSH terms
- Animals, Antigen-Antibody Complex, Autoantibodies, Blood Platelets, Humans, Lupus Erythematosus, Systemic, Mitochondria, Receptors, IgG, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.